Brentuximab vedotin
Brentuximab vedotin is to be available on the NHS in Scotland for first-line treatment of systemic anaplastic large cell lymphoma.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Brentuximab vedotin is to be available on the NHS in Scotland for first-line treatment of systemic anaplastic large cell lymphoma.
The UK NHS is under extreme pressure, but it is important you don't ignore symptoms.
Lymphoma Action respond to frequently asked questions about the COVID-19 vaccines
2021 is a special year for Lymphoma Action, as we mark our 35-year anniversary!
New European guidelines give evidence-based recommendations for the diagnosis, treatment and follow-up of people with follicular lymphoma.
People who are clinically extremely vulnerable - including people with lymphoma - are advised to take extra precautions to protect themselves.
Recently added podcasts cover emotional wellbeing and mental health and why lymphoma is so interesting.
As we head into the festive period, we wanted to take the opportunity to say a heartfelt thank you for your support over the past year.
The Department of Health and Social Care (DHSC) explain the different vaccines and answer commonly asked questions about the COVID-19 vaccine.
The UK’s COVID-19 vaccination programme has now started following the UK approval of the first COVID-19 vaccine on the 2 December. The government recommends that people who are at higher risks of becoming seriously ill due to COVID-19 should have the vaccine when it is offered to them, which includes people affected by lymphoma.